List of Tables
Table 1. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Injection
Table 5. Key Players of Solution
Table 6. Key Players of Other
Table 7. Global Drugs for Treating Mental Disorders Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Drugs for Treating Mental Disorders Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Drugs for Treating Mental Disorders Market Share by Region (2017-2022)
Table 11. Global Drugs for Treating Mental Disorders Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Drugs for Treating Mental Disorders Market Share by Region (2023-2028)
Table 13. Drugs for Treating Mental Disorders Market Trends
Table 14. Drugs for Treating Mental Disorders Market Drivers
Table 15. Drugs for Treating Mental Disorders Market Challenges
Table 16. Drugs for Treating Mental Disorders Market Restraints
Table 17. Global Drugs for Treating Mental Disorders Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Drugs for Treating Mental Disorders Revenue Share by Players (2017-2022)
Table 19. Global Top Drugs for Treating Mental Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2021)
Table 20. Ranking of Global Top Drugs for Treating Mental Disorders Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Drugs for Treating Mental Disorders Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drugs for Treating Mental Disorders Product Solution and Service
Table 24. Date of Enter into Drugs for Treating Mental Disorders Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2017-2022)
Table 28. Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Drugs for Treating Mental Disorders Revenue Market Share by Type (2023-2028)
Table 30. Global Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Drugs for Treating Mental Disorders Revenue Share by Application (2017-2022)
Table 32. Global Drugs for Treating Mental Disorders Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Drugs for Treating Mental Disorders Revenue Share by Application (2023-2028)
Table 34. North America Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Drugs for Treating Mental Disorders Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Drugs for Treating Mental Disorders Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Drugs for Treating Mental Disorders Market Size by Country (2023-2028) & (US$ Million)
Table 64. Johnson and Johnson Company Details
Table 65. Johnson and Johnson Business Overview
Table 66. Johnson and Johnson Drugs for Treating Mental Disorders Product
Table 67. Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 68. Johnson and Johnson Recent Developments
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Drugs for Treating Mental Disorders Product
Table 72. Pfizer Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 73. Pfizer Recent Developments
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Drugs for Treating Mental Disorders Product
Table 77. Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 78. Eli Lilly Recent Developments
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Drugs for Treating Mental Disorders Product
Table 82. GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 83. GlaxoSmithKline Recent Developments
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Drugs for Treating Mental Disorders Product
Table 87. AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 88. AstraZeneca Recent Developments
Table 89. Bristol-Myers Squibb Company Details
Table 90. Bristol-Myers Squibb Business Overview
Table 91. Bristol-Myers Squibb Drugs for Treating Mental Disorders Product
Table 92. Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 93. Bristol-Myers Squibb Recent Developments
Table 94. Teva Pharmaceutical Company Details
Table 95. Teva Pharmaceutical Business Overview
Table 96. Teva Pharmaceutical Drugs for Treating Mental Disorders Product
Table 97. Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 98. Teva Pharmaceutical Recent Developments
Table 99. Dr. Reddy's Laboratories Company Details
Table 100. Dr. Reddy's Laboratories Business Overview
Table 101. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Product
Table 102. Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 103. Dr. Reddy's Laboratories Recent Developments
Table 104. Apotex Inc. Company Details
Table 105. Apotex Inc. Business Overview
Table 106. Apotex Inc. Drugs for Treating Mental Disorders Product
Table 107. Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 108. Apotex Inc. Recent Developments
Table 109. Mylan Pharmaceuticals Company Details
Table 110. Mylan Pharmaceuticals Business Overview
Table 111. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 112. Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 113. Mylan Pharmaceuticals Recent Developments
Table 114. Par Pharmaceutical Company Details
Table 115. Par Pharmaceutical Business Overview
Table 116. Par Pharmaceutical Drugs for Treating Mental Disorders Product
Table 117. Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 118. Par Pharmaceutical Recent Developments
Table 119. Aurobindo Pharma Company Details
Table 120. Aurobindo Pharma Business Overview
Table 121. Aurobindo Pharma Drugs for Treating Mental Disorders Product
Table 122. Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 123. Aurobindo Pharma Recent Developments
Table 124. Torrent Pharmaceuticals Company Details
Table 125. Torrent Pharmaceuticals Business Overview
Table 126. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 127. Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 128. Torrent Pharmaceuticals Recent Developments
Table 129. Jubilant Lifesciences Company Details
Table 130. Jubilant Lifesciences Business Overview
Table 131. Jubilant Lifesciences Drugs for Treating Mental Disorders Product
Table 132. Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 133. Jubilant Lifesciences Recent Developments
Table 134. Sun Pharmaceutical Company Details
Table 135. Sun Pharmaceutical Business Overview
Table 136. Sun Pharmaceutical Drugs for Treating Mental Disorders Product
Table 137. Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 138. Sun Pharmaceutical Recent Developments
Table 139. Sandoz (Novartis) Company Details
Table 140. Sandoz (Novartis) Business Overview
Table 141. Sandoz (Novartis) Drugs for Treating Mental Disorders Product
Table 142. Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 143. Sandoz (Novartis) Recent Developments
Table 144. Hansoh Pharmaceutical Company Details
Table 145. Hansoh Pharmaceutical Business Overview
Table 146. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Product
Table 147. Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 148. Hansoh Pharmaceutical Recent Developments
Table 149. WATSON Pharmaceuticals Company Details
Table 150. WATSON Pharmaceuticals Business Overview
Table 151. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 152. WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 153. WATSON Pharmaceuticals Recent Developments
Table 154. Zhejiang Langhua Pharmaceuticals Company Details
Table 155. Zhejiang Langhua Pharmaceuticals Business Overview
Table 156. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 157. Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 158. Zhejiang Langhua Pharmaceuticals Recent Developments
Table 159. Forest Laboratories Company Details
Table 160. Forest Laboratories Business Overview
Table 161. Forest Laboratories Drugs for Treating Mental Disorders Product
Table 162. Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 163. Forest Laboratories Recent Developments
Table 164. H.Lundbeck A/S Company Details
Table 165. H.Lundbeck A/S Business Overview
Table 166. H.Lundbeck A/S Drugs for Treating Mental Disorders Product
Table 167. H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 168. H.Lundbeck A/S Recent Developments
Table 169. Amneal Pharmaceuticals Company Details
Table 170. Amneal Pharmaceuticals Business Overview
Table 171. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 172. Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 173. Amneal Pharmaceuticals Recent Developments
Table 174. Hetero Drugs Company Details
Table 175. Hetero Drugs Business Overview
Table 176. Hetero Drugs Drugs for Treating Mental Disorders Product
Table 177. Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 178. Hetero Drugs Recent Developments
Table 179. Macleods Pharmaceuticals Company Details
Table 180. Macleods Pharmaceuticals Business Overview
Table 181. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 182. Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 183. Macleods Pharmaceuticals Recent Developments
Table 184. Silarx Pharmacueticals Company Details
Table 185. Silarx Pharmacueticals Business Overview
Table 186. Silarx Pharmacueticals Drugs for Treating Mental Disorders Product
Table 187. Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 188. Silarx Pharmacueticals Recent Developments
Table 189. Hikma Pharmaceuticals Company Details
Table 190. Hikma Pharmaceuticals Business Overview
Table 191. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Product
Table 192. Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 193. Hikma Pharmaceuticals Recent Developments
Table 194. Lupin Limited Company Details
Table 195. Lupin Limited Business Overview
Table 196. Lupin Limited Drugs for Treating Mental Disorders Product
Table 197. Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 198. Lupin Limited Recent Developments
Table 199. Prinston Pharmaceutical Company Details
Table 200. Prinston Pharmaceutical Business Overview
Table 201. Prinston Pharmaceutical Drugs for Treating Mental Disorders Product
Table 202. Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 203. Prinston Pharmaceutical Recent Developments
Table 204. STI Pharma Company Details
Table 205. STI Pharma Business Overview
Table 206. STI Pharma Drugs for Treating Mental Disorders Product
Table 207. STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2017-2022) & (US$ Million)
Table 208. STI Pharma Recent Developments
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Treating Mental Disorders Market Share by Type: 2021 VS 2028
Figure 2. Tablets Features
Figure 3. Capsule Features
Figure 4. Injection Features
Figure 5. Solution Features
Figure 6. Other Features
Figure 7. Global Drugs for Treating Mental Disorders Market Share by Application: 2021 VS 2028
Figure 8. Antipsychotics Case Studies
Figure 9. Antidepressants Case Studies
Figure 10. Antianxiety (Anxiolyitcs) Case Studies
Figure 11. Anti-Seizure Medications Case Studies
Figure 12. Stimulants Case Studies
Figure 13. Cognitive Disorders And Dementia Case Studies
Figure 14. Sleep Disorder Treatments Case Studies
Figure 15. Substance Abuse Treatments Case Studies
Figure 16. Hypnosis And Tranquilizers Case Studies
Figure 17. Other Case Studies
Figure 18. Drugs for Treating Mental Disorders Report Years Considered
Figure 19. Global Drugs for Treating Mental Disorders Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 20. Global Drugs for Treating Mental Disorders Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Drugs for Treating Mental Disorders Market Share by Region: 2021 VS 2028
Figure 22. Global Drugs for Treating Mental Disorders Market Share by Players in 2021
Figure 23. Global Top Drugs for Treating Mental Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2021)
Figure 24. The Top 10 and 5 Players Market Share by Drugs for Treating Mental Disorders Revenue in 2021
Figure 25. North America Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
Figure 26. North America Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
Figure 27. North America Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
Figure 28. North America Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
Figure 29. United States Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Canada Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Europe Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Europe Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
Figure 33. Europe Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
Figure 34. Europe Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
Figure 35. Germany Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. France Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. U.K. Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Italy Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Russia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Nordic Countries Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Asia-Pacific Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Asia Pacific Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
Figure 43. Asia Pacific Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
Figure 44. Asia Pacific Drugs for Treating Mental Disorders Market Size Share by Region (2017-2028)
Figure 45. China Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Japan Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. South Korea Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Southeast Asia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. India Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Australia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 51. Latin America Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Latin America Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
Figure 53. Latin America Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
Figure 54. Latin America Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
Figure 55. Mexico Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Brazil Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Middle East & Africa Drugs for Treating Mental Disorders Market Size YoY (2017-2028) & (US$ Million)
Figure 58. Middle East and Africa Drugs for Treating Mental Disorders Market Size Market Share by Type (2017-2028)
Figure 59. Middle East and Africa Drugs for Treating Mental Disorders Market Size Market Share by Application (2017-2028)
Figure 60. Middle East and Africa Drugs for Treating Mental Disorders Market Size Share by Country (2017-2028)
Figure 61. Turkey Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 62. Saudi Arabia Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 63. UAE Drugs for Treating Mental Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 64. Johnson and Johnson Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 65. Pfizer Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 66. Eli Lilly Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 68. AstraZeneca Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 70. Teva Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 71. Dr. Reddy's Laboratories Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 72. Apotex Inc. Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 73. Mylan Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 74. Par Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 75. Aurobindo Pharma Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 76. Torrent Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 77. Jubilant Lifesciences Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 78. Sun Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 79. Sandoz (Novartis) Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 80. Hansoh Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 81. WATSON Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 82. Zhejiang Langhua Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 83. Forest Laboratories Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 84. H.Lundbeck A/S Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 85. Amneal Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 86. Hetero Drugs Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 87. Macleods Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 88. Silarx Pharmacueticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 89. Hikma Pharmaceuticals Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 90. Lupin Limited Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 91. Prinston Pharmaceutical Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 92. STI Pharma Revenue Growth Rate in Drugs for Treating Mental Disorders Business (2017-2022)
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
